From: A categorical network approach for discovering differentially expressed regulations in cancer
Name | GEO Ref | Platform | Disease Condition | Class Criteria | Samples by Class | Reference |
---|---|---|---|---|---|---|
BRS1 | GSE1456 | GPL96 | Breast | survival status | 119+40 | [25] |
BRS2 | GSE3494 | GPL96 | Cancer | Â | 181+55 | [26] |
BER1 | GSE2990 | GPL96 | Breast | ER status | 34+149 | [27] |
BER2 | GSE7390 | GPL96 | Cancer | neg. vs. pos. | 64+134 | [28] |
BER3 | GSE20711 | GPL570 | Â | Â | 45+42 | [29] |
BER4 | GSE2034 | GPL96 | Â | Â | 77+209 | [30] |
LNG1 | GSE10245 | GPL570 | Lung | adenocarcen. | 18+40 | [31] |
LNG2 | GSE18842 | GPL570 | Cancer | vs. | 32+14 | [32] |
LNG3 | GSE31799 | GPL14189 | Â | squamous cell | 20+29 | [33] |
GST1 | GSE33335 | GPL5175 | Gastric | tumor | 25+25 | [34] |
GST2 | GSE27342 | GPL5175 | Cancer | vs. normal | 80+80 | [35] |
GST3 | GSE37023 | GPL96 | Â | Â | 112+39 | [36] |
KDN1 | GSE15641 | GPL96 | Clear Cell | disease | 32+23 | [37] |
KDN2 | GSE17818 | GPL9101 | Renal Cancer | vs. control | 102+13 | [38] |
KDN3 | GSE22316 | GPL10175 | Â | Â | 70+13 | [39] |